LAURA HULL: Open Payments
NPI 1306269337 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,796 in 145 payments from 29 companies in 2025. Trend: 2023 $2,660 · 2024 $2,914 · 2025 $2,796
Food & beverage: $2,796
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $351 |
| Amgen Inc. | 13 | $297 |
| Abbott Laboratories | 16 | $287 |
| Medtronic, Inc. | 12 | $279 |
| Insulet Corporation | 10 | $212 |
| Madrigal Pharmaceuticals | 7 | $174 |
| Mannkind Corporation | 12 | $156 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $119 |
| Radius Health, Inc. | 4 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $91 |
Products named: FREESTYLE LIBRE, MINIMED 780G, TEPEZZA, Omnipod, Wegovy, REZDIFFRA, AFREZZA, Ozempic.
Industry payments across TX — which companies pay providers there.
